A Chronic Obstructive Pulmonary Disease Exacerbation Following the Administration of a COVID 19-Booster Vaccine: A Case Report.
J Community Hosp Intern Med Perspect
; 12(5): 110-113, 2022.
Article
in English
| MEDLINE | ID: covidwho-2081656
ABSTRACT
We present a case of a patient who presented to the emergency department with symptoms suggestive of a chronic obstructive pulmonary disease (COPD) exacerbation one day after receiving the BNT162b2 COVID-19 booster vaccine. Laboratory studies indicated she was in a state of inflammation, but not infection. Other potential triggers, including cardiac and viral etiologies, were ruled out. To our knowledge, this is the first documented case of a COPD exacerbation following the administration of the BNT162b2 COVID-19 vaccine.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
/
Etiology study
Topics:
Vaccines
Language:
English
Journal:
J Community Hosp Intern Med Perspect
Year:
2022
Document Type:
Article
Affiliation country:
2000-9666.1107
Similar
MEDLINE
...
LILACS
LIS